October 2022
New Manufacturing Technology Platforms for Biosimilars

One of the main drivers for the pipeline growth in biosimilars is the number of originator blockbuster molecules coming off patent -17 blockbuster molecules with annual peak sales worth $60 billion have or will lose exclusivity between 2020 and 2025.

View PDF